Jove
Visualize
Contact Us

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author reply: Moving from feasibility to clinical validation of using artificial intelligence to classify and segment fundus images with choroidal nevi.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Utility value reporting in uveal melanoma: a critical gap for cost-effectiveness analyses.

Eye (London, England)·2026
Same author

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Cancers·2026
Same author

Early genetic evolution of driver mutations in uveal melanoma.

Nature communications·2025
Same author

In Need of Structured Recovery, Ocular Oncology Needs Enhanced Recovery after Surgery.

Ocular oncology and pathology·2025
Same author

Early Genetic Evolution of Driver Mutations in Uveal Melanoma.

medRxiv : the preprint server for health sciences·2025
Same journal

Eye injury rates and community cost savings through vision centers: Evidence from southern India.

Indian journal of ophthalmology·2026
Same journal

Evaluation of the protective efficiency of polycarbonate goggles against firecracker-related ocular injuries.

Indian journal of ophthalmology·2026
Same journal

Comment on: Clinical characteristics, risk factor analysis, and outcomes of graft rejection after Descemet membrane endothelial keratoplasty.

Indian journal of ophthalmology·2026
Same journal

Issue regarding E Log book for PG students: Paper to pixels.

Indian journal of ophthalmology·2026
Same journal

Methylation matters: A case control study on epigenetic alteration in diabetic retinopathy.

Indian journal of ophthalmology·2026
Same journal

Understanding the disconnect: A pilot study of public perception versus reality of corneal donation in India.

Indian journal of ophthalmology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 23, 2026

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Thyroid associated orbitopathy.

Rajat Maheshwari1, Ezekiel Weis

  • 1Department of Ophthalmology, Royal Alexendra Hospital, University of Alberta, Edmonton, Alberta, Canada T5H 3V9. rajat.oculoplasty@gmail.com

Indian Journal of Ophthalmology
|March 27, 2012
PubMed
Summary
This summary is machine-generated.

Thyroid associated orbitopathy, or Graves' orbitopathy, is an autoimmune condition affecting the eyes. Research continues to seek better understanding and treatments for this challenging condition.

More Related Videos

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Related Experiment Videos

Last Updated: May 23, 2026

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Autoimmune Diseases

Background:

  • Thyroid associated orbitopathy (TAO), also known as Graves' orbitopathy, is an autoimmune condition linked to thyroid dysfunction.
  • It presents a spectrum of severity, from mild symptoms to sight-threatening complications.
  • Despite research, its exact cause and optimal treatments are not fully understood.

Purpose of the Study:

  • To review the current understanding of TAO.
  • To discuss the pathophysiology, clinical presentation, and management strategies.
  • To highlight the challenges in diagnosing and treating this condition.

Main Methods:

  • Literature review of existing research on TAO.
  • Analysis of clinical presentations and diagnostic criteria.
  • Evaluation of current and emerging therapeutic approaches.

Main Results:

  • TAO is a complex autoimmune process with variable clinical manifestations.
  • Effective therapeutic strategies and a complete understanding of pathogenesis are still lacking.
  • Management remains a significant challenge for ophthalmologists.

Conclusions:

  • Further research is crucial to elucidate the pathogenesis of TAO.
  • Development of more effective and targeted therapies is needed.
  • Improved diagnostic and management protocols are essential for better patient outcomes.